Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 44% ± 12% | |
lung | 14 studies | 41% ± 17% | |
intestine | 10 studies | 26% ± 9% | |
kidney | 8 studies | 31% ± 10% | |
eye | 5 studies | 29% ± 10% | |
uterus | 4 studies | 43% ± 20% | |
lymph node | 4 studies | 39% ± 7% | |
breast | 4 studies | 36% ± 8% | |
brain | 4 studies | 21% ± 3% | |
pancreas | 3 studies | 49% ± 19% | |
bone marrow | 3 studies | 32% ± 14% | |
prostate | 3 studies | 36% ± 13% | |
liver | 3 studies | 39% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1978.21 | 1444 / 1445 | 100% | 150.05 | 183 / 183 |
uterus | 100% | 1721.17 | 170 / 170 | 100% | 124.21 | 458 / 459 |
brain | 100% | 4956.84 | 2637 / 2642 | 100% | 100.44 | 704 / 705 |
adrenal gland | 100% | 8599.10 | 258 / 258 | 100% | 161.13 | 229 / 230 |
thymus | 100% | 1674.62 | 651 / 653 | 100% | 131.11 | 603 / 605 |
intestine | 100% | 1694.67 | 966 / 966 | 99% | 140.45 | 523 / 527 |
prostate | 100% | 2872.20 | 245 / 245 | 99% | 82.67 | 498 / 502 |
ovary | 99% | 1167.97 | 178 / 180 | 100% | 292.29 | 430 / 430 |
skin | 100% | 3316.82 | 1809 / 1809 | 98% | 97.98 | 464 / 472 |
bladder | 100% | 3119.38 | 21 / 21 | 98% | 133.88 | 495 / 504 |
stomach | 99% | 1453.77 | 356 / 359 | 99% | 150.97 | 283 / 286 |
breast | 100% | 2205.08 | 459 / 459 | 97% | 76.04 | 1089 / 1118 |
pancreas | 98% | 1558.81 | 322 / 328 | 99% | 121.31 | 176 / 178 |
lung | 99% | 1759.64 | 573 / 578 | 98% | 88.63 | 1129 / 1155 |
kidney | 100% | 2214.70 | 89 / 89 | 88% | 61.26 | 796 / 901 |
liver | 91% | 881.84 | 206 / 226 | 94% | 60.80 | 383 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 124.74 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 179.59 | 29 / 29 |
spleen | 100% | 2709.31 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 96.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 304.94 | 1 / 1 |
adipose | 100% | 2097.65 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2550.11 | 1329 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2632.02 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 1381.30 | 837 / 861 | 0% | 0 | 0 / 0 |
muscle | 80% | 739.42 | 643 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045110 | Biological process | intermediate filament bundle assembly |
GO_0008150 | Biological process | biological_process |
GO_0005575 | Cellular component | cellular_component |
GO_0030054 | Cellular component | cell junction |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0120219 | Cellular component | subapical part of cell |
GO_0070161 | Cellular component | anchoring junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0005882 | Cellular component | intermediate filament |
GO_0005515 | Molecular function | protein binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | BBLN |
Protein name | Bublin coiled-coil protein (UPF0184 protein C9orf16) |
Synonyms | C9orf16 EST00098 |
Description | FUNCTION: Essential for intermediate filament organization in intestinal cells, interacts with intermediate filament and regulates intestinal lumen morphology. . |
Accessions | ENST00000372994.2 Q9BUW7 |